Besides its protective role, an emerging concept is that constitutive activation of NRF2 and its target genes can result in promotion of tumor growth and resistance to oxidants and anticancer drugs in a number of tumor types [6, 16, 17]. This evidence concerns the gene NFE2L2 and neoplasm.